- Home
- ATYR vs NGS Comparison
ATYR vs NGS Comparison
Compare ATYR & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- NGS
- Stock Information
- Founded
- ATYR 2005
- NGS 1998
- Country
- ATYR United States
- NGS United States
- Employees
- ATYR N/A
- NGS N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- NGS Oilfield Services/Equipment
- Sector
- ATYR Health Care
- NGS Energy
- Exchange
- ATYR Nasdaq
- NGS Nasdaq
- Market Cap
- ATYR 451.3M
- NGS 312.1M
- IPO Year
- ATYR 2015
- NGS 2002
- Fundamental
- Price
- ATYR $5.31
- NGS $25.95
- Analyst Decision
- ATYR Strong Buy
- NGS Strong Buy
- Analyst Count
- ATYR 6
- NGS 2
- Target Price
- ATYR $20.20
- NGS $32.50
- AVG Volume (30 Days)
- ATYR 3.5M
- NGS 84.5K
- Earning Date
- ATYR 08-12-2025
- NGS 08-13-2025
- Dividend Yield
- ATYR N/A
- NGS N/A
- EPS Growth
- ATYR N/A
- NGS 76.16
- EPS
- ATYR N/A
- NGS 1.34
- Revenue
- ATYR N/A
- NGS $161,218,000.00
- Revenue This Year
- ATYR $960.85
- NGS $13.56
- Revenue Next Year
- ATYR $1,283.47
- NGS $15.42
- P/E Ratio
- ATYR N/A
- NGS $19.03
- Revenue Growth
- ATYR N/A
- NGS 22.64
- 52 Week Low
- ATYR $1.48
- NGS $16.70
- 52 Week High
- ATYR $5.98
- NGS $29.74
- Technical
- Relative Strength Index (RSI)
- ATYR 57.23
- NGS 51.60
- Support Level
- ATYR $4.96
- NGS $25.13
- Resistance Level
- ATYR $5.47
- NGS $27.00
- Average True Range (ATR)
- ATYR 0.37
- NGS 1.10
- MACD
- ATYR -0.07
- NGS -0.23
- Stochastic Oscillator
- ATYR 61.11
- NGS 22.33
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.